OKUR vs TXN · P/E 72, rev $2.0M vs P/E 52, rev $10.29B
OnKure Therapeutics, Inc. (OKUR) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the OKUR and TXN stock pages for the full models.
Not investment advice.